Net profit of Syncom Formulations (India) rose 73.41% to Rs 7.63 crore in the quarter ended June 2024 as against Rs 4.40 crore during the previous quarter ended June 2023. Sales rose 45.82% to Rs 87.26 crore in the quarter ended June 2024 as against Rs 59.84 crore during the previous quarter ended June 2023.
Particulars | Quarter Ended |
| Jun. 2024 | Jun. 2023 | % Var. |
Sales | 87.26 | 59.84 | 46 |
OPM % | 11.98 | 10.80 | - |
PBDT | 11.40 | 7.21 | 58 |
PBT | 10.10 | 6.11 | 65 |
NP | 7.63 | 4.40 | 73 |